Abstract
Purpose
To evaluate the prevalence and impact of various predictive factors including diabetes control in malignant external otitis (MEO) treatment response.
Methods
In a cross-sectional study on MEO patients, we defined treatment response with three indices; ESR level decrease, hospitalization period, and systemic antifungal drug usage. The impact of diabetes control and other predictive factors on these indices have been evaluated.
Results
Overall, 164 patients with a mean age of 67.8 ± 9.7 years were included. Cranial nerve involvement was present in 56 patients. Nine patients had immunodeficiency. 19.5% of cases had leukocytosis. Diabetes mellitus was present in 156 patients, suffering for an average of 13.9 ± 8.6 years. The overall mean hemoglobin A1C (HbA1c) level was 8.3% (4.4–12.8%), and the mean fasting blood sugar was 146.4 mg/dl (63–292 mg/dl). 29.3% of patients had good diabetes control before admission (HbA1c < 7%), 54.9% had poor control (7% < HbA1c < 10%) and 15.9% had very poor glycemic control (HbA1c > 10%). The predictive role for the following factors were not statistically significant: age, gender, comorbidities, diabetes, diabetes management method used before and during hospitalization, diabetes duration, leukocytosis, immunodeficiency, fasting blood sugar level, HbA1c level, glycemic control index, and insulin amount. However, CRP level with a mean value of 34.3 mg/L showed a significant correlation with ESR decrease, hospitalization period, and antifungal drug usage.
Conclusion
CRP level could be used as a predictor for the hospitalization period, the need for systemic antifungal and ESR level decrease. It would be helpful to check the CRP level at the time of diagnosis to predict the hospitalization period and the necessity of systemic antifungal management to adjust the treatment strategy.
Similar content being viewed by others
References
Franco-Vidal V, Blanchet H, Bebear C, Dutronc H, Darrouzet V (2007) Necrotizing external otitis: a report of 46 cases. Otol Neurotol 28(6):771–773. https://doi.org/10.1097/MAO.0b013e31805153bd
Loh S, Loh WS (2013) Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors. Otolaryngol Head Neck Surg 148(6):991–996. https://doi.org/10.1177/0194599813482107
Lee SK, Lee SA, Seon SW, Jung JH, Lee JD, Choi JY et al (2017) Analysis of prognostic factors in malignant external otitis. Clin Exp Otorhinolaryngol. 10(3):228–235. https://doi.org/10.21053/ceo.2016.00612
Carfrae MJ, Kesser BW (2008) Malignant otitis externa. Otolaryngol Clin N Am 41(3):537–549. https://doi.org/10.1016/j.otc.2008.01.004 (viii–ix)
Nawas MT, Daruwalla VJ, Spirer D, Micco AG, Nemeth AJ (2013) Complicated necrotizing otitis externa. Am J Otolaryngol 34(6):706–709. https://doi.org/10.1016/j.amjoto.2013.07.003
Dabiri S, Karrabi N, Yazdani N, Rahimian A, Kheiltash A, Hasibi M et al (2020) Facial nerve paralysis in malignant otitis externa: comparison of the clinical and paraclinical findings. Acta Otolaryngol 27:1–5. https://doi.org/10.1080/00016489.2020.1808242
Sreepada GS, Kwartler JA (2003) Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg 11(5):316–323. https://doi.org/10.1097/00020840-200310000-00002
Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI (2008) Predicting outcome of malignant external otitis. Otol Neurotol 29(3):339–343. https://doi.org/10.1097/MAO.0b013e3181661879
Orji FT, Akpeh JO, Ukaegbe OC (2017) Malignant otitis externa: an assessment of emerging pathogens and the prognostic factors. Int J Med Med Sci 9(7):86–91. https://doi.org/10.5897/IJMMS2017.1305
Chin R, Roche P, Sigston E, Valance N (2012) Malignant otitis externa: an Australian case series. Surgeon 10(5):273–277. https://doi.org/10.1016/j.surge.2011.09.004
Hine JL, de Lusignan S, Burleigh D, Pathirannehelage S, McGovern A, Gatenby P et al (2017) Association between glycaemic control and common infections in people with Type 2 diabetes: a cohort study. Diabet Med 34(4):551–557. https://doi.org/10.1111/dme.13205
Casqueiro J, Casqueiro J, Alves C (2012) Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 16(Suppl 1):S27–S36. https://doi.org/10.4103/2230-8210.94253
Hasibi M, Ashtiani MK, Motassadi Zarandi M, Yazdani N, Borghei P, Kuhi A et al (2017) A treatment protocol for management of bacterial and fungal malignant external otitis: a large cohort in Tehran. Iran Ann Otol Rhinol Laryngol 126(7):561–567. https://doi.org/10.1177/0003489417710473
Marina S, Goutham MK, Rajeshwary A, Vadisha B, Devika T (2019) A retrospective review of 14 cases of malignant otitis externa. J Otol 14(2):63–66. https://doi.org/10.1016/j.joto.2019.01.003
Rothholtz VS, Lee AD, Shamloo B, Bazargan M, Pan D, Djalilian HR (2008) Skull base osteomyelitis: the effect of comorbid disease on hospitalization. Laryngoscope 118(11):1917–1924. https://doi.org/10.1097/MLG.0b013e31817fae0d
Stevens SM, Lambert PR, Baker AB, Meyer TA (2015) Malignant otitis externa: a novel stratification protocol for predicting treatment outcomes. Otol Neurotol 36(9):1492–1498. https://doi.org/10.1097/MAO.0000000000000839
Soudry E, Hamzany Y, Preis M, Joshua B, Hadar T, Nageris BI (2011) Malignant external otitis: analysis of severe cases. Otolaryngol Head Neck Surg 144(5):758–762. https://doi.org/10.1177/0194599810396132
Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY (2010) Outcomes of malignant external otitis: survival vs mortality. Acta Otolaryngol 130(1):89–94. https://doi.org/10.3109/00016480902971247
Ridder GJ, Breunig C, Kaminsky J, Pfeiffer J (2015) Central skull base osteomyelitis: new insights and implications for diagnosis and treatment. Eur Arch Otorhinolaryngol 272(5):1269–1276. https://doi.org/10.1007/s00405-014-3390-y
Lee S, Hooper R, Fuller A, Turlakow A, Cousins V, Nouraei R (2008) Otogenic cranial base osteomyelitis: a proposed prognosis-based system for disease classification. Otol Neurotol 29(5):666–672. https://doi.org/10.1097/MAO.0b013e318179972f
Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR (2007) Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope 117(5):907–910. https://doi.org/10.1097/MLG.0b013e318039b30f
Soudry E, Joshua BZ, Sulkes J, Nageris BI (2007) Characteristics and prognosis of malignant external otitis with facial paralysis. Arch Otolaryngol Head Neck Surg 133(10):1002–1004. https://doi.org/10.1001/archotol.133.10.1002
Gabay C, Kushner I (1999) Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340(6):448–454. https://doi.org/10.1056/NEJM199902113400607
Margulis I, Cohen-Kerem R, Roitman A, Gez-Reder H, Aviram A, Bitterman-Fisher S, Kugelman N, Doweck I (2022) Laboratory and imaging findings of necrotizing otitis externa are associated with pathogen type and disease outcome: a retrospective analysis. Ear Nose Throat J 19:1455613221080973. https://doi.org/10.1177/01455613221080973
Durojaiye OC, Slucka A, Kritsotakis EI (2022) Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa. Eur J Clin Microbiol Infect Dis. https://doi.org/10.1007/s10096-022-04455-y
Faizal B, Surendran B, Kumar M (2020) Comparative study of reliability of inflammatory markers over 18-FDG-PET CT scan in monitoring skull base osteomyelitis. Braz J Otorhinolaryngol. https://doi.org/10.1016/j.bjorl.2020.09.012
Abu Eta R, Gavriel H, Stephen K, Eviatar E, Yeheskeli E (2018) The significance of tissue biopsy for fungi in necrotizing otitis externa. Eur Arch Otorhinolaryngol 275(12):2941–2945. https://doi.org/10.1007/s00405-018-5151-9
Ali T, Meade K, Anari S, ElBadawey MR, Zammit-Maempel I (2010) Malignant otitis externa: case series. J Laryngol Otol 124(8):846–851. https://doi.org/10.1017/S0022215110000691
Geerlings SE, Hoepelman AI (1999) Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 26(3–4):259–265. https://doi.org/10.1111/j.1574-695X.1999.tb01397.x
O’Sullivan TJ, Dickson RI, Blokmanis A, Roberts FJ, Kaan K (1978) The pathogenesis, differential diagnosis, and treatment of malignant otitis externa. J Otolaryngol 7(4):297–303
Lucente FE, Parisier SC, Som PM, Arnold LM (1982) Malignant external otitis: a dangerous misnomer? Otolaryngol Head Neck Surg 90(2):266–269. https://doi.org/10.1177/019459988209000223
Lucente FE, Parisier SC, Som PM (1983) Complications of the treatment of malignant external otitis. Laryngoscope 93(3):279–281. https://doi.org/10.1288/00005537-198303000-00005
Driscoll PV, Ramachandrula A, Drezner DA, Hicks TA, Schaffer SR (1993) Characteristics of cerumen in diabetic patients: a key to understanding malignant external otitis? Otolaryngol Head Neck Surg 109(4):676–679. https://doi.org/10.1177/019459989310900407
Habra B, Mghari GE, Ansari NE (2018) Malignant external otitis in diabetic patients. Endocrinol Metab Int J. 6(3):173–175. https://doi.org/10.15406/emij.2018.06.00173
Singh G, Pitoyo CW, Aditianingsih D, Rumende CM (2016) Risk factors for early invasive fungal disease in critically ill patients. Indian J Crit Care Med 20(11):633–639. https://doi.org/10.4103/0972-5229.194007
Peleg AY, Weerarathna T, McCarthy JS, Davis TM (2007) Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res Rev 23(1):3–13. https://doi.org/10.1002/dmrr.682
Acknowledgements
This research was done as a medical graduation thesis in Amir Alam Hospital which is affiliated with Tehran University of Medical Sciences.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Contributions
AZ contributed to conceptualization, methodology, investigation, writing—original draft, formal analysis, and data curation. AJ was involved in writing—review and editing, resources, and data curation. SD contributed to methodology, project administration, and formal analysis. MH contributed to resources and validation. AT performed validation. NK contributed to resources. NY did supervision.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no competing interests to declare that are relevant to the content of this article.
Ethics approval
This study was approved by the Ethics Committee at Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1397.413). The clinical investigations were all conducted according to the principles expressed in the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Zonnour, A., Jamshidi, A., Dabiri, S. et al. Predictive factors in treatment response of malignant external otitis. Eur Arch Otorhinolaryngol 280, 159–166 (2023). https://doi.org/10.1007/s00405-022-07478-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-022-07478-5